Atlas Trials

High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL

Clinical trial NCT03123718 · UNKNOWN

Trial details

NCT number
NCT03123718
Sponsor
Chonnam National University Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
DLBCL
Start date
2017-07-01
Primary completion
2021-06-30
Enrollment
205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.